| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |